Want to keep on top of the science and politics driving biotech these days? Sign up to get our biotech newsletter in your inbox.
Hello! Today, we get some optimism from the new director of the Countrywide Cancer Institute, irrespective of a brain drain actively playing out in the marketplace and stagnant funding numbers. Also, advocates press the federal governing administration to encourage production for the prostate cancer drug Xtandi.
Study the rest…